Objective: To identify the molecular basis of a demyelinating Charcot-Marie
-Tooth disease type 1 (CMT1) with presumed autosomal recessive inheritance.
Background: CMT1, an inherited motor and sensory neuropathy with low nerve
conduction velocities, is caused by dominantly inherited mutations in the
genes of the peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ
/P-0), and early growth response 2 transcription factor (EGR2/Krox-20). Pat
ients and methods: Two young sisters born of clinically and electrophysiolo
gically healthy parents had a severe CMT1 neuropathy of presumed autosomal
recessive inheritance, The older sister underwent a nerve biopsy. The autho
rs analyzed PMP22, MPZ/P-0 and EGR2/Krox-20 by automated direct nucleotide
sequencing. For rapid mutation detection, they determined the restriction-f
ragment-length polymorphisms for TaqI in the fluorescein-labeled target DNA
sequence amplified by PCR. Results: Nerve biopsy disclosed a demyelinating
and remyelinating neuropathy with onion bulb formations. Both sisters had
a novel heterozygous G(308)-->A transition of MPZ/P-0 without any mutation
of PMP22 or EGR2/Krox-20. The G(308)-->A transition was a nonconservative m
utation that changed a glycine into a glutamate at the amino acid residue 7
4 in the extracellular domain of the mature MPZ/P-0. None of 50 healthy con
trols had the mutation. The healthy mother had a low amount of the mutation
in blood (congruent to 20%) as well as in skin, buccal epithelium, and hai
rs (30%). Because the healthy mother carried clones of somatic mutant cells
and had transmitted the G(308)-->A transition to the affected daughters, s
he also harbored germline mutant cells. Conclusion: In hereditary demyelina
ting neuropathies, somatic and germline mosaicism of dominant mutations in
the myelin protein genes may mimic autosomal recessive inheritance.